Literature DB >> 10319976

Proton MR spectroscopy in patients with complex partial seizures: single-voxel spectroscopy versus chemical-shift imaging.

Y Y Hsu1, C Chang, C N Chang, N S Chu, K E Lim, J C Hsu.   

Abstract

BACKGROUND AND
PURPOSE: Proton MR spectroscopy has recently been applied to the evaluation of seizures, but few comparisons have been made between different clinical spectroscopic techniques. Our goal was to determine whether there is a significant difference between hippocampal NAA/(Cho+Cr) ratios obtained by single-voxel spectroscopy (SVS) and by chemical-shift imaging (CSI).
METHODS: Twelve healthy adults and eight patients with complex partial seizures were studied on a 1.5-T MR scanner using a proton SVS method. Another 12 healthy adults and 10 patients with complex partial seizures were recruited for a proton CSI study, which was performed on a different 1.5-T MR system. The NAA/(Cho+Cr) ratio was calculated from the integral peak areas by curve fitting. The two-tailed t-test was used for statistical analysis.
RESULTS: The mean value +/- standard deviation of the hippocampal NAA/(Cho+Cr) ratio in healthy control subjects was 0.63 +/- 0.07 by SVS, with 0.62 +/- 0.15 for the anterior hippocampus and 0.65 +/- 0.11 for the posterior hippocampus by CSI. There was no significant difference between the control group data obtained by SVS and those by CSI, nor was there a regional difference in the CSI NAA/(Cho+Cr) ratio in the hippocampus. Relative to the control group, the patients with seizures had a significant decrease in the NAA/(Cho+Cr) ratio in the abnormal hippocampus: -28% by SVS, and -24% in the anterior hippocampus and -18% in the posterior hippocampus by CSI. Proton SVS and CSI detected hippocampal abnormalities, unilateral or bilateral, in all patients of each group.
CONCLUSION: Under similar measurement conditions, proton SVS and CSI provide similar NAA/(Cho+Cr) ratios among healthy control subjects, and they possess comparable ability for detecting hippocampal abnormalities in patients with complex partial seizures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10319976

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  6 in total

Review 1.  Neurochemistry of drug action: insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction.

Authors:  Stephanie C Licata; Perry F Renshaw
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

2.  Diagnosis of mesial temporal sclerosis: sensitivity, specificity and predictive values of the quantitative analysis of magnetic resonance imaging.

Authors:  Ana María Granados Sánchez; Juan Felipe Orejuela Zapata
Journal:  Neuroradiol J       Date:  2017-09-13

3.  Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy.

Authors:  A Cianfoni; S Niku; S G Imbesi
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

4.  N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).

Authors:  Jerzy Walecki; Maria Barcikowska; Jarosław B Ćwikła; Tomasz Gabryelewicz
Journal:  Med Sci Monit       Date:  2011-12

5.  Comparative Lateralizing Ability of Multimodality MRI in Temporal Lobe Epilepsy.

Authors:  Karabekir Ercan; Hediye Pinar Gunbey; Erhan Bilir; Elcin Zan; Halil Arslan
Journal:  Dis Markers       Date:  2016-11-15       Impact factor: 3.434

6.  Assessment of changes in brain metabolites in Indian patients with type-2 diabetes mellitus using proton magnetic resonance spectroscopy.

Authors:  Sanjeev Sinha; Meera Ekka; Uma Sharma; Raghunandan P; R M Pandey; N R Jagannathan
Journal:  BMC Res Notes       Date:  2014-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.